Currency in INR
| Earnings Estimate | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|
| No. of Analysts | 1 | 1 | 16 | 15 |
| Avg. Estimate | 1.7 | 2.19 | 7.47 | 13.1 |
| Low Estimate | 1.7 | 2.19 | 4.8 | 7.9 |
| High Estimate | 1.7 | 2.19 | 9.99 | 17.35 |
| Year Ago EPS | 0.85 | 1.25 | 8.63 | 7.47 |
| Revenue Estimate | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|
| No. of Analysts | 1 | 1 | 17 | 16 |
| Avg. Estimate | 35.26B | 37.47B | 163.09B | 194.13B |
| Low Estimate | 35.26B | 37.47B | 153.91B | 171.54B |
| High Estimate | 35.26B | 37.47B | 180.63B | 214.81B |
| Year Ago Sales | 35.99B | N/A | 21.27B | 163.09B |
| Sales Growth (year/est) | -2.00% | N/A | 666.60% | 19.00% |
| Earnings History | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 |
|---|
| EPS Est. | 1.68 | 1.46 | 1.62 | 1.3 |
| EPS Actual | 0.85 | 1.25 | 5.33 | 1.2 |
| Difference | -0.83 | -0.21 | 3.71 | -0.1 |
| Surprise % | -49.40% | -14.40% | 229.00% | -7.70% |
| EPS Trend | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|
| Current Estimate | 1.7 | 2.19 | 7.47 | 13.1 |
| 7 Days Ago | 1.7 | 2.19 | 7.47 | 13.1 |
| 30 Days Ago | 1.19 | 1.6 | 8.05 | 13.07 |
| 60 Days Ago | 2.85 | 3.15 | 8.38 | 13.37 |
| 90 Days Ago | 2.85 | 3.15 | 8.38 | 13.33 |
| EPS Revisions | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2025) | Next Year (2026) |
|---|
| Up Last 7 Days | N/A | N/A | N/A | N/A |
| Up Last 30 Days | 1 | 1 | 4 | 6 |
| Down Last 7 Days | N/A | N/A | N/A | N/A |
| Down Last 30 Days | N/A | N/A | N/A | N/A |
| Growth Estimates | BIOCON.NS | Industry | Sector(s) | S&P 500 |
|---|
| Current Qtr. | 100.00% | N/A | N/A | N/A |
| Next Qtr. | 75.20% | N/A | N/A | N/A |
| Current Year | -13.40% | N/A | N/A | N/A |
| Next Year | 75.40% | N/A | N/A | N/A |
| Next 5 Years (per annum) | 62.70% | N/A | N/A | N/A |
| Past 5 Years (per annum) | 2.91% | N/A | N/A | N/A |
